Science Advances Impact Factor 2026: Trend, Rankings & What Authors Need to Know

Decision cue: If you need a yes/no submission call today, compare your draft with 3 recent accepted papers from this journal and only submit when scope, methods depth, and claim strength line up.

Related: How to choose a journal • How to avoid desk rejection • Pre-submission checklist

Science Advances has an impact factor of 12.5 in 2024, based on Clarivate's Journal Citation Reports released in June 2025. That's up from a low of 11.7 in 2023 and puts the journal comfortably in the top tier of open-access multidisciplinary publishing.

If you're deciding whether to submit there, the raw IF number only tells part of the story. Here's what the trend actually means, how Science Advances compares to the journals competing for the same manuscripts, and what you should realistically expect from a submission.

What is the Science Advances Impact Factor?

The impact factor measures how often articles published in the previous two years were cited during the current year. For Science Advances' 2024 IF:

• Numerator: total citations in 2024 to articles published in 2022 and 2023
• Denominator: total citable articles published in 2022 and 2023
• Result: 12.5

Clarivate releases updated IFs annually, usually in June. The "2024 impact factor" became available in June 2025 and reflects 2024 citation patterns.

Science Advances Impact Factor by Year (2017-2024)

Source: Clarivate JCR 2025 (2024 data). All figures are official two-year journal impact factors.

Reading the trend

Science Advances launched in 2015 and built steadily through its early years. The peak in 2021 at 15.0 reflected the same COVID-era citation surge that inflated IFs across most high-impact journals: papers from 2019 and 2020 got cited heavily as researchers quickly built on pandemic-related and adjacent work.

The 2022-2023 drop was sharp but predictable. As COVID citation inflation normalized, journals across all fields saw declines. Science Advances fell from 15.0 to 11.7 over two years, a 22% drop. That's real, but not alarming: the same pattern played out at Nature Communications, PNAS, and most multidisciplinary journals.

The 2024 recovery to 12.5 is a good sign. It suggests the journal's citation base is stabilizing around a sustainable floor rather than continuing to erode.

How Science Advances Ranks vs Similar Journals

IF doesn't mean much in isolation. Here's how Science Advances compares to the journals most researchers consider alongside it:

A few things stand out from this table:

Science Advances is more selective than its IF suggests. With a 10% post-review acceptance rate, it's harder to publish in than Nature Communications (IF 15.7) despite a lower IF. The AAAS brand gives editors the latitude to be picky.

PNAS has a lower IF but carries comparable prestige. A PNAS paper in most fields is considered roughly equivalent to Science Advances. PNAS is cheaper (especially if your institution is a member) and generally faster.

The APC is real money. At $5,000, Science Advances costs roughly the same as Cell Reports and nearly double PNAS. If your institution has an AAAS read-and-publish deal, this may be covered: worth checking before you submit.

What the Impact Factor Actually Tells Reviewers and Hiring Committees

For most research evaluation contexts, an IF of 12.5 puts Science Advances in a clear tier:

• Clear top-tier: Nature/Science/Cell and their flagship siblings (IF 30+)
• Strong high-impact: Nature Communications, Science Advances, PNAS, PLOS Biology (IF 8-20)
• Solid specialist journals: Cell Reports, Nucleic Acids Research, JCI (IF 6-14)
• Broad-scope journals: Scientific Reports, PLOS ONE (IF 2-6)

For hiring committees and grant reviewers in most biomedical and physical science fields, a Science Advances paper reads as a solid high-impact publication. It's not a CNS paper, but it's well above the noise.

For tenure and promotion cases specifically, the journal's open-access nature is increasingly a positive signal rather than a neutral one, particularly at institutions with strong OA commitments.

Is the Science Advances IF Still Recovering?

It's a fair question. The drop from 15.0 to 11.7 over 2021-2023 was steep enough that some researchers started treating Science Advances as a lower-tier target than they had before.

The 2024 recovery to 12.5 is encouraging, but one year of data doesn't confirm a trend. A few things suggest the floor is behind us:

• Science Advances still publishes ~3,000 papers per year with strong methodological quality
• AAAS brand strength hasn't changed: this is still the organization that publishes Science itself
• Post-COVID IF normalization has stabilized across most journals in the 2023-2024 window
• The 5-year IF sits at approximately 14.1, which better reflects the journal's long-term citation performance

For most researchers, the 2024 figure of 12.5 is the one to use. The historical peak at 15.0 is not coming back in the near term, and the 11.7 from 2023 was likely the trough.

Should You Submit to Science Advances?

Submit to Science Advances if your paper meets most of these:

• [ ] The work crosses disciplinary boundaries or has clear implications beyond your specialty
• [ ] Your result would interest scientists in at least two different fields
• [ ] You can write a 2-sentence statement explaining why the finding matters outside your subfield
• [ ] Your institution has AAAS journal coverage, or you can cover the $5,000 APC
• [ ] The AAAS brand carries particular weight in your field (common in physical and interdisciplinary sciences)
• [ ] You're comfortable with a 21-28 day decision timeline
• [ ] Your paper is complete - Science Advances has limited appetite for "first report" papers without mechanistic follow-through

Do not submit if:

• Your paper is a strong advance within one specialty but doesn't cross fields (Nature Communications is the better call)
• Your institution has Springer Nature coverage but no AAAS agreement (Nature Communications becomes significantly cheaper in practice)
• Your work is primarily clinical or epidemiological (PNAS or field-specific journals are better fits)

The honest comparison with PNAS: Both are AAAS portfolio journals targeting similar manuscripts. Science Advances has a higher IF (12.5 vs 9.1) but PNAS is cheaper ($0-1,830 APC vs $5,000). For most multidisciplinary biology papers, PNAS is more cost-effective at comparable prestige. If AAAS journal coverage is important but cost isn't the constraint, Science Advances offers the brand with faster turnaround.

Bottom Line

Science Advances' 2024 impact factor of 12.5 reflects a journal that took the same post-COVID IF hit as most of its peers and is now stabilizing. The brand hasn't changed, the selectivity hasn't changed, and the audience it delivers papers to hasn't changed.

For strong interdisciplinary work with broad appeal, it remains one of the best open-access venues available. Just know going in that desk rejection is common, the APC is substantial, and reviewers will hold you to a high bar on significance claims.

For more on the journals that compete for similar manuscripts, see our guides to Nature Communications and PNAS.

For a full evaluation of whether Science Advances is right for your paper, see Is Science Advances a good journal?.

What Science Advances' IF Means in Practice

Science Advances' IF of 12.5 sits above most field-specific journals but below the Nature Portfolio journals. For promotion and tenure purposes, a Science Advances paper registers as a strong journal publication , better than most specialty journals, short of Nature-portfolio or top field-specific journals.

The practical advantage is open access at no cost to the author. For researchers at institutions without broad publisher agreements, this is meaningful. A paper in Science Advances is immediately available to any reader globally without an APC charge to the author or an institutional subscription requirement for the reader.

The Science Advances Brand and What It Signals

AAAS , the publisher of Science , has built significant journal prestige through Science magazine over more than 140 years. Science Advances inherits some of that brand recognition. Hiring committees and grant reviewers who recognize the AAAS connection understand that Science Advances has a meaningful editorial bar, even if they're unfamiliar with the specific IF.

This brand recognition is particularly valuable in interdisciplinary fields where journal hierarchies are less clearly established than in single-discipline fields. A Science Advances paper signals "this passed AAAS editorial standards" without requiring the reader to know where it sits in a specific field's pecking order.

2026 Freshness Check: The No-APC Advantage

The most important Science Advances update in 2026 isn't the IF, it's cost structure. For many labs, the no-APC model is now a decisive advantage over comparably ranked open-access journals charging several thousand dollars.

That changes submission behavior: authors who previously defaulted to Nature Communications are more often choosing Science Advances when the paper's scope and quality fit both journals. The prestige gap is narrower than most people think, and the budget gap is real.

If your institution doesn't have strong publisher agreements, this is one of the highest-value submission targets in the top open-access tier.

The Bottom Line

Science Advances sits in a useful spot for authors who need open access without paying an APC and want AAAS validation. The IF of 12.5 is competitive but not out of reach for strong work in the right fields. Before you submit, know where your manuscript stands , the desk rejection rate runs around ~40%, so preparation matters.

Sources

• Journal Citation Reports (Clarivate Analytics) , annual impact factor data
• SCImago Journal & Country Rank , h-index and citation metrics
• Journal official author guidelines (linked from each journal's homepage)
• Pre-Submission Checklist , 25-point audit before you submit

See also

• Nature Communications vs Science Advances